Morrison Foerster advised Medios AG ("Medios"), Germany’s leading provider of specialty pharma solutions, on the launch of a public share buyback offer of up to one million shares. This marked the first share buyback offer conducted by Medios. The offer covered approximately 3.92% of the current share capital of Medios. The acceptance period began on 20 June 2025 and ended on 8 July 2025.
Morrison Foerster has been advising Medios on a wide range of complex transactions since its IPO in 2016. In this transaction as well, the firm supported the company with its comprehensive capital markets experience.
The Morrison Foerster team: Dr. Dirk Besse (Partner), Dr. Sebastian Schwalme (Partner), Jennifer Seipelt (Partner), Julian Gebauer (Counsel), Tobias Flatt (Associate)